William Woods
Stock Analyst at B. Riley Securities
(0.67)
# 4,195
Out of 5,149 analysts
12
Total ratings
30.77%
Success rate
-11.38%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Buy | $7 | $1.69 | +314.20% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $425.85 | +57.33% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.70 | +194.12% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.02 | +194.12% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $2.91 | +243.64% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $1.07 | +367.29% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.52 | +1,884.13% | 1 | May 14, 2024 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $4 | $4.77 | -16.14% | 1 | Mar 14, 2024 |
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.69
Upside: +314.20%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $425.85
Upside: +57.33%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.70
Upside: +194.12%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.02
Upside: +194.12%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.91
Upside: +243.64%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $1.07
Upside: +367.29%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.52
Upside: +1,884.13%
KORU Medical Systems
Mar 14, 2024
Reiterates: Buy
Price Target: $4
Current: $4.77
Upside: -16.14%